English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/32782
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

Functional characterization of three single–nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA– protein interactions.

AutorMaloney, Bryan; Ge, Yuan-Wen; Petersen, Ronald D.; Hardy, John; Rogers, Jack T.; Pérez-Tur, Jordi ; Lahiri, Debomoy K.
Palabras claveEnvejecimiento
Alzheimer
Demencia
Genética
Regulación génica
APOE
Fecha de publicación5-ene-2010
EditorWiley-Blackwell
CitaciónAmerican Journal of Medical Genetics - Neuropsych Genetics Part B
ResumenVariations in levels of apolipoprotein E (ApoE) have been tied to the risk and progression of Alzheimer’s disease (AD). Our group has previously compared and contrasted the promoters of the mouse and human ApoE gene (APOE) promoter sequences and found notable similarities and significant differences that suggest the importance of the APOE promoter’s role in the human disease. We examine here three specific single–nucleotide polymorphisms within the human APOE promoter region, specifically at −219 (G/T), −427 (T/C), and at −491 (A/T) upstream from the +1 transcription start site. The −219 and −491 polymorphic variations have significant association with instance of AD, and −491AA has significant risk even when stratified for the APOEε4 allele. We also show significant effects on reporter gene expression in neuronal cell cultures, and, notably, these effects are modified by species origin of the cells. The −491 and −219 polymorphisms may have an interactive effect in addition to any independent activity. DNA–protein interactions differ between each polymorphic state. We propose SP1 and GATA as candidates for regulatory control of the −491 and −219 polymorphic sites. This work’s significance lies in drawing connection among APOE promoter polymorphisms’ associations with AD to functional promoter activity differences and specific changes in DNA–protein interactions with cell culture-based assays. Taken together, these results suggest that APOE expression levels are a risk factor for AD irrespective of APOEε4 allele status.
Versión del editor10.1002/ajmg.b.30973
URIhttp://hdl.handle.net/10261/32782
ISSN1552-4841
Aparece en las colecciones: (IBV) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
APOE-tripolymorphism text_Final.pdf895,62 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.